Hours after Britain approved the Oxford University-AstraZeneca COVID-19 vaccine, India’s expert panel met on Wednesday to review the data before submitting its final recommendation for approval. The entire process is likely to take a week and the announcement is likely to be known next week. The Subject Expert Committee of the Central Drug Standard Control Organization (CDSCO) apparently pondered the ...

Finally, a Covid-19 vaccine developed by Oxford University’s Jenner Institute and licensed to the multinational pharmaceutical company, AstraZeneca has emerged as the favourite of World Health Organization scientists out of about 23 vaccines in their Phase III trial, after reporting success and safety in the first two phases. For India, this vaccine is important as AstraZeneca, among others, had entered ...

Any Covid-19 vaccine? All nations and the entire world humanity was eagerly awaiting the precious announcement from at least one top nation that its scientists have successfully completed clinical trials of Covid-19 vaccine. When expectations were running high that it would be China, where the novel coronavirus had its origin in the city of Wuhan, unexpectedly Russia has announced first ...

American pharmaceutical giant Pfizer has announced that its ongoing development of a COVID-19 vaccine could be ready in five months period by October end. Pfizer is working on the vaccine project in collaboration with German firm Biontech. Pfizer and its vaccine development German partner BioNTech announced on Friday, May 29, that the first participants have been given the doses in ...

US vaccine maker Inovio Pharmaceuticals said on Wednesday that its experimental vaccine to prevent coronavirus infection produced protective antibodies and immune system responses in mice and guinea pigs, raising hopes that it could provide relief if Moderna’s vaccine fails. The company’s shares, which have more than quadrupled this year on hopes of its vaccine working, surged another 18% to $15.77 ...

Important lessons learned from the Severe Acute Respiratory Syndrome (SARS) outbreak of 2002-2003 could inform and guide vaccine design for COVID-19 according to University of Melbourne Professor Kanta Subbarao, Director of the WHO Centre for Reference. In an article published Thursday in Cell Host and Microbe, Prof. Kanta Subbarao stressed the importance of detecting a neutralising antibody response in recovered ...

AstraZeneca Plc agreed to make an experimental coronavirus vaccine developed by Oxford University researchers as the race for vaccine heats up. In India, the Serum Institute, the world’s largest maker of vaccines by volume, has already started producing millions of doses of the Oxford University shot and it remains to be seen whether market share will be entered at a ...